Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care
- PMID: 32984103
- PMCID: PMC7491774
- DOI: 10.4103/jfmpc.jfmpc_527_20
Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care
Abstract
Gastric carcinoma represents the second most common type of malignancy that contributes to cancer-related mortality worldwide. However, the geographic incidence of gastric carcinoma had changed over the last few decades, possibly due to increased hygiene, increased awareness of the importance of healthy nutrition, and increased rates of eradication of Helicobacter pylori infection. Gastric carcinoma consists of two pathological variants, intestinal and diffuse. Early cases of gastric carcinoma may be asymptomatic. However, advanced cases may present with significant weight loss, dysphagia, abdominal pain, vomiting, and even severe upper gastrointestinal bleeding. Patients at high risk of developing gastric carcinoma should be adequately screened at primary healthcare centers for early detection and effective management. Lines of treatment vary according to the stage of the disease but surgical resection of the tumor with regional lymphadenectomy remains the gold standard of therapy. This review sheds light on gastric carcinoma given the recent trends regarding its prevalence, risk factors, types, clinical picture, methods of diagnosis, possible lines of management, and the role of primary care.
Keywords: Carcinoma; diagnosis; management; primary care; stomach.
Copyright: © 2020 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Gastric cancer: epidemiology, prevention, classification, and treatment.Cancer Manag Res. 2018 Feb 7;10:239-248. doi: 10.2147/CMAR.S149619. eCollection 2018. Cancer Manag Res. 2018. PMID: 29445300 Free PMC article. Review.
-
Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.Arq Gastroenterol. 2006 Oct-Dec;43(4):288-92. doi: 10.1590/s0004-28032006000400009. Arq Gastroenterol. 2006. PMID: 17406757 Clinical Trial.
-
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.Lancet. 2008 Aug 2;372(9636):392-7. doi: 10.1016/S0140-6736(08)61159-9. Lancet. 2008. PMID: 18675689 Clinical Trial.
-
Association of Helicobacter pylori with carcinoma of stomach.J Pak Med Assoc. 2007 Jul;57(7):337-41. J Pak Med Assoc. 2007. PMID: 17867254
-
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609640
Cited by
-
Diagnostic Potential of miR-143-5p, miR-143-3p, miR-551b-5p, and miR-574-3p in Chemoresistance of Locally Advanced Gastric Cancer: A Preliminary Study.Int J Mol Sci. 2024 Jul 24;25(15):8057. doi: 10.3390/ijms25158057. Int J Mol Sci. 2024. PMID: 39125625 Free PMC article.
-
Falling Trend in the Epidemiology of Gastric Cancer in Mississippi From 2003 to 2019: What Mississippi Got Right.Cureus. 2022 Nov 13;14(11):e31440. doi: 10.7759/cureus.31440. eCollection 2022 Nov. Cureus. 2022. PMID: 36408310 Free PMC article.
-
Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of gastric cancer through regulation of FKBP5-mediated AKT1/mTORC1 signaling pathway.Cell Cycle. 2022 Dec;21(24):2590-2601. doi: 10.1080/15384101.2022.2105092. Epub 2022 Aug 25. Cell Cycle. 2022. PMID: 36005478 Free PMC article.
-
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.Clin Epidemiol. 2021 Jul 2;13:515-525. doi: 10.2147/CLEP.S304332. eCollection 2021. Clin Epidemiol. 2021. PMID: 34239328 Free PMC article.
-
Pembrolizumab in combination with trastuzumab for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer.Ann Med Surg (Lond). 2024 Jun 21;86(8):4647-4656. doi: 10.1097/MS9.0000000000002305. eCollection 2024 Aug. Ann Med Surg (Lond). 2024. PMID: 39118760 Free PMC article. Review.
References
-
- Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. - PubMed
Publication types
LinkOut - more resources
Full Text Sources